<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35036978</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-6065</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The Lancet regional health. Western Pacific</Title><ISOAbbreviation>Lancet Reg Health West Pac</ISOAbbreviation></Journal><ArticleTitle>Changing epidemiology of hand, foot, and mouth disease in China, 2013-2019: a population-based study.</ArticleTitle><Pagination><StartPage>100370</StartPage><MedlinePgn>100370</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100370</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lanwpc.2021.100370</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hand, foot, and mouth disease (HFMD) is an important public health problem. A monovalent EV-A71 vaccine was launched in China in 2016. Previous studies showed that inactivated monovalent EV-A71 vaccines were highly efficient against HFMD associated with EV-A71 but not against HFMD with other etiologies, leading to a hypothesis that the introduction of EV-A71 vaccines might change the pathogen spectrum and epidemiological trend of HFMD. In this study, we described for the first time the changing epidemiological characteristics of HFMD after the launch of the EV-A71 vaccine.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We extracted individual-based epidemiological data on HFMD cases reported to the Chinese Center for Disease Control and Prevention between January 2013 and December 2019. We described the changing epidemiological characteristics of HFMD before and after vaccine launch according to the distribution of diseases characteristics (demographic, temporal, and geographical) and evaluated the potential changes in risk factors of severe patients. All analyses were stratified by the phase before and after vaccine launch, and by enterovirus serotype.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">During 2013-2019, 15,316,710 probable cases of HFMD were reported. Of these, 787,197 (5&#xb7;1%) were laboratory confirmed and 76,982 (0&#xb7;5%) were severe. After the launch of the EV-A71 vaccine, the median age of HFMD patients infected with EV-A71 increased from 2&#xb7;24 years (IQR:1&#xb7;43, 3&#xb7;56) to 2&#xb7;81 years (IQR:1&#xb7;58, 4&#xb7;01). The proportion of patients less than 3 years of age decreased while the proportion of patients 3-5 years of age increased. There was a large decrease (60&#xb7;7%) in the proportion of severe cases as well as a decline (28&#xb7;3%) in HFMD patients infected with EV-A71. After the launch of the EV-A71 vaccine, the severe illness rate and mortality rate of HFMD patients in all age groups has decreased sharply, 62&#xb7;20% and 83&#xb7;78% respectively. The timing of the HFMD epidemic peak was delayed (1-2 months) . After the launch of EV-A71 vaccine, the risk of becoming a severe case for EV-A71 serotype was decreased, whereas that risk was instead increased for CV-A16 (from 0&#xb7;17 (95% CI:0&#xb7;16, 0&#xb7;18) to 0&#xb7;23 (95% CI:0&#xb7;21, 0&#xb7;25)) and other enterovirus compared to EV-A71 (from 0&#xb7;38 (95% CI:0&#xb7;37, 0&#xb7;39) to 0&#xb7;58 (95% CI:0&#xb7;56, 0&#xb7;61)). The longer the time from onset to diagnosis, the higher was the risk of being a severe case, but the effect size was decreased.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">The introduction of the EV-A71 vaccine has effectively reduced the proportion of severe HFMD cases and mortality, but changes to the dominant serotypes should be closely monitored. Development of multivalent vaccines to avoid an increased case burden due to other enteroviruses is greatly needed.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">This research was supported by the National Natural Science Foundation of China (81973102, 81773487), Public Health Talents Training Program of Shanghai Municipality (GWV-10.2-XD21), the 5th Three-year Action Program of Shanghai Municipality for Strengthening the Construction of Public Health System (GWV-10.1-XK05), the Major Project of Scientific and Technical Winter Olympics from National Key Research and Development Program of China (2021YFF0306000), 13th Five-Year National Science and Technology Major Project for Infectious Diseases (2018ZX10725-509) and Key projects of the PLA logistics Scientific research Program (BHJ17J013).</AbstractText><CopyrightInformation>&#xa9; 2021 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, Fudan University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Fengfeng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Hongchao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Erasmus University Medical Center, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Geology and Geography, Georgia Southern University, Statesboro, GA, 30460, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Sydney School of Veterinary Science, The University of Sydney, Camden, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Minrui</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, Fudan University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, Fudan University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jiaqi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, Fudan University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, Fudan University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Jiaxu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, Fudan University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, Fudan University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cowling</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Public Health, the University of Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhongjie</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Health Commission of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Zhaorui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhijie</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, Fudan University, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Reg Health West Pac</MedlineTA><NlmUniqueID>101774968</NlmUniqueID><ISSNLinking>2666-6065</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Changing epidemiology</Keyword><Keyword MajorTopicYN="N">Comparative study</Keyword><Keyword MajorTopicYN="N">Enterovirus 71 vaccine</Keyword><Keyword MajorTopicYN="N">HFMD</Keyword></KeywordList><CoiStatement>We declare that we have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35036978</ArticleId><ArticleId IdType="pmc">PMC8743221</ArticleId><ArticleId IdType="doi">10.1016/j.lanwpc.2021.100370</ArticleId><ArticleId IdType="pii">S2666-6065(21)00279-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang J, Hu T, Sun D, et al. Epidemiological characteristics of hand, foot, and mouth disease in Shandong, China, 2009-2016. Sci Rep. 2017;7(1):8900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567189</ArticleId><ArticleId IdType="pubmed">28827733</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin DQ, Wang CB, Wang CB, Xiao Z, Ji SX. Epidemiology Characteristics of Human Coxsackievirus A16 and Enterovirus 71 Circulating in Linyi, China, from 2009 to 2017. Jpn J Infect Dis. 2018;71(6):470&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">29962487</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Yeo A, Phoon MC, et al. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis. 2010;14(12):e1076&#x2013;e1081.</Citation><ArticleIdList><ArticleId IdType="pubmed">20952237</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu AC, Greenblatt DT. In: Infectious Diseases (Third Edition) Cohen J, Opal SM, Powderly WG, editors. Mosby; London: 2010. Chapter 12 - Dermatologic manifestations of systemic infections; pp. 140&#x2013;146.</Citation></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9(11):1097&#x2013;1105.</Citation><ArticleIdList><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi S, Liao Q, Van Boeckel TP, et al. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination. PLoS Med. 2016;13(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4755668</ArticleId><ArticleId IdType="pubmed">26882540</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Liu L, Mo Z, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370(9):829&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JX, Song YF, Wang L, et al. Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children. Expert Rev Vaccines. 2016;15(1):129&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">26460695</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Jiang L, Zhang C, He W, Tan Y, Ning C. The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine. Vaccine. 2021;39(25):3319&#x2013;3323.</Citation><ArticleIdList><ArticleId IdType="pubmed">33994239</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Zhang Z, Rao Q, et al. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China. Emerg Microbes Infect. 2021;10(1):619&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8018479</ArticleId><ArticleId IdType="pubmed">33682641</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Chen Z, Zheng K, et al. Epidemiology of Hand, Foot, and Mouth Disease Before and After the Introduction of Enterovirus 71 Vaccines in Chengdu, China, 2009-2018. Pediatr Infect Dis J. 2020;39(10):969&#x2013;978.</Citation><ArticleIdList><ArticleId IdType="pubmed">32433221</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Jiang H, Tian X, Xia X, Huang T. Ongoing Epidemiological Changes in Hand, Foot, and Mouth Disease Following the Introduction of Enterovirus 71 Vaccines in Yunnan Province, China, 2008-2019; 2021.</Citation></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014;14(4):308&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian L, Liang F, Xu M, Jia L, Pan X, Clements ACA. Spatio-temporal analysis of the relationship between meteorological factors and hand-foot-mouth disease in Beijing, China. BMC Infect Dis. 2018;18(1):158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5883540</ArticleId><ArticleId IdType="pubmed">29614964</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong ZM, Wang HH, Wang YJ, Wang WR. Spatiotemporal analysis of hand, foot and mouth disease data using time-lag geographically-weighted regression. Geospat Health. 2020;15(2)</Citation><ArticleIdList><ArticleId IdType="pubmed">33461279</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Lai Y, Du Z, et al. Spatiotemporal Distribution of Hand, Foot, and Mouth Disease in Guangdong Province, China and Potential Predictors, 2009&#x207b;2012. Int J Environ Res Public Health. 2019;16(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6480297</ArticleId><ArticleId IdType="pubmed">30987085</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Wu P, Wu JT, et al. Seroprevalence of Enterovirus 71 Antibody Among Children in China: A Systematic Review and Meta-analysis. Pediatr Infect Dis J. 2015;34(12):1399&#x2013;1406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718881</ArticleId><ArticleId IdType="pubmed">26368058</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z, Huang Y, Lawrence WR, et al. Leading Enterovirus Genotypes Causing Hand, Foot, and Mouth Disease in Guangzhou, China: Relationship with Climate and Vaccination against EV71. Int J Environ Res Public Health. 2021;18(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7795377</ArticleId><ArticleId IdType="pubmed">33401757</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JL, Yuan J, Yang F, et al. Epidemic characteristics of hand, foot, and mouth disease in southern China, 2013: coxsackievirus A6 has emerged as the predominant causative agent. J Infect. 2014;69(3):299&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">24731881</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo WP, Lin XD, Chen YP, et al. Fourteen types of co-circulating recombinant enterovirus were associated with hand, foot, and mouth disease in children from Wenzhou, China. J Clin Virol. 2015;70:29&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">26305816</ArticleId></ArticleIdList></Reference><Reference><Citation>Hongyan G, Chengjie M, Qiaozhi Y, et al. Hand, foot and mouth disease caused by coxsackievirus A6, Beijing, 2013. Pediatr Infect Dis J. 2014;33(12):1302&#x2013;1303.</Citation><ArticleIdList><ArticleId IdType="pubmed">25037037</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JF, Xu S, Zhang Y, et al. Hand, foot, and mouth disease outbreak caused by coxsackievirus A6, China, 2013. J Infect. 2014;69(3):303&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">24704297</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Yuan J, Wang X, et al. Severe hand, foot, and mouth disease and coxsackievirus A6-Shenzhen, China. Clin Infect Dis. 2014;59(10):1504&#x2013;1505.</Citation><ArticleIdList><ArticleId IdType="pubmed">25091307</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Zeng H, Zheng H, et al. Hand, foot and mouth disease in Guangdong, China, in 2013: new trends in the continuing epidemic. Clin Microbiol Infect. 2014;20(7):O442&#x2013;O445.</Citation><ArticleIdList><ArticleId IdType="pubmed">24428125</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Sun Y, Du Y, et al. Characterization of Coxsackievirus A6- and Enterovirus 71-Associated Hand Foot and Mouth Disease in Beijing, China, from 2013 to 2015. Front Microbiol. 2016;7:391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4812011</ArticleId><ArticleId IdType="pubmed">27065963</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan X, Li L, Zhang B, et al. Molecular epidemiology of coxsackievirus A6 associated with outbreaks of hand, foot, and mouth disease in Tianjin, China, in 2013. Arch Virol. 2015;160(4):1097&#x2013;1104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4629805</ArticleId><ArticleId IdType="pubmed">25680566</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Zhu R, Yang Y, et al. Phylogenetic analysis of the major causative agents of hand, foot and mouth disease in Suzhou City, Jiangsu province, China, in 2012-2013. Emerg Microbes Infect. 2015;4(2):e12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4345287</ArticleId><ArticleId IdType="pubmed">26038764</ArticleId></ArticleIdList></Reference><Reference><Citation>Salleras L, Dom&#xed;nguez A, Ciruela P, et al. Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine. Clin Microbiol Infect. 2009;15(11):997&#x2013;1001.</Citation><ArticleIdList><ArticleId IdType="pubmed">19689466</ArticleId></ArticleIdList></Reference><Reference><Citation>Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. Jama. 2007;297(16):1784&#x2013;1792.</Citation><ArticleIdList><ArticleId IdType="pubmed">17456820</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet. 2011;378(9807):1962&#x2013;1973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3256741</ArticleId><ArticleId IdType="pubmed">21492929</ArticleId></ArticleIdList></Reference><Reference><Citation>He YQ, Chen L, Xu WB, et al. Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China. J Clin Microbiol. 2013;51(11):3560&#x2013;3566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3889734</ArticleId><ArticleId IdType="pubmed">23966496</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>